ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma

Xia, Zhi-Nan; Wu, Jing-Gen; Yao, Wen-Hao; Meng, Yu-Yang; Jian, Wen-Gang; Wang, Teng-Da; Xue, Wei; Yu, Yi-Peng; Cai, Li-Cheng; Wang, Xing-Yuan; Zhang, Peng; Li, Zhi-Yuan; Zhou, Hao; Jiang, Zhi-Cheng; Zhou, Jia-Yu; Zhang, Cheng*哈尔滨医科大学; 浙江大学; 1
Scientific Reports2022-6-29DOI: 10.1038/s41598-022-15206-6
4被引11阅读
引用收藏
分享

摘要

Renal cell carcinoma (RCC) is a kidney cancer that is originated from the lined proximal convoluted tubule, and its major histological subtype is clear cell RCC (ccRCC). This study aimed to retrospectively analyze single-cell RNA sequencing (scRNA-seq) data from the Gene Expression Omnibus (GEO) database, to explore the correlation among the evolution of tumor microenvironment (TME), clinical outcomes, and potential immunotherapeutic responses in combination with bulk RNA-seq data from The Cancer Genome Atlas (TCGA) database, and to construct a differentiation-related genes (DRG)-based prognostic risk signature (PRS) and a nomogram to predict the prognosis of ccRCC patients. First, scRNA-seq data of ccRCC samples were systematically analyzed, and three subsets with distinct differentiation trajectories were identified. Then, ccRCC samples from TCGA database were divided into four DRG-based molecular subtypes, and it was revealed that the molecular subtypes were significantly correlated with prognosis, clinicopathological features, TME, and the expression levels of immune checkpoint genes (ICGs). A DRG-based PRS was constructed, and it was an independent prognostic factor, which could well predict the prognosis of ccRCC patients. Finally, we constructed a prognostic nomogram based on the PRS and clinicopathological characteristics, which exhibited a high accuracy and a robust predictive performance. This study highlighted the significance of trajectory differentiation of ccRCC cells and TME evolution in predicting clinical outcomes and potential immunotherapeutic responses of ccRCC patients, and the nomogram provided an intuitive and accurate method for predicting the prognosis of such patients.

学科与关键词

关键词
INTRATUMOR HETEROGENEITYEVOLUTIONTUMORCHECKPOINT
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2022-06-29
卷期
第 12 卷, 第 1 期
页码
10973
DOI
10.1038/s41598-022-15206-6
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81872084]

作者

  • X

    Xia, Zhi-Nan (第一作者)

    1 · harbin med univ

  • W

    Wu, Jing-Gen

    zhejiang univ

查看全部 16 位作者收起作者
  • Y

    Yao, Wen-Hao

    1 · harbin med univ

  • M

    Meng, Yu-Yang

    1 · harbin med univ

  • J

    Jian, Wen-Gang

    1 · harbin med univ

  • W

    Wang, Teng-Da

    1 · harbin med univ

  • X

    Xue, Wei

    1 · harbin med univ

  • Y

    Yu, Yi-Peng

    1 · harbin med univ

  • C

    Cai, Li-Cheng

    1 · harbin med univ

  • W

    Wang, Xing-Yuan

    1 · harbin med univ

  • Z

    Zhang, Peng

    1 · harbin med univ

  • L

    Li, Zhi-Yuan

    1 · harbin med univ

  • Z

    Zhou, Hao

    zhejiang univ

  • J

    Jiang, Zhi-Cheng

    zhejiang univ

  • Z

    Zhou, Jia-Yu

  • Z

    Zhang, Cheng (通讯)

    zhejiang univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417